Aberdeen Group plc Buys 494,370 Shares of American Healthcare REIT, Inc. $AHR

Key Points

• Aberdeen Group plc increased its stake in American Healthcare REIT, acquiring 494,370 shares, resulting in a total ownership of approximately 1.34 million shares, valued at $49.15 million.
• Wall Street analysts show strong confidence in AHR, with Baird R W upgrading to "strong-buy" and several firms raising their price targets, leading to an average consensus target price of $44.11.
• American Healthcare REIT announced a quarterly dividend of $0.25, which will be paid on October 17th, representing an annualized yield of 2.5%.

Aberdeen Group plc lifted its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 58.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,337,748 shares of the company's stock after acquiring an additional 494,370 shares during the period. Aberdeen Group plc owned approximately 0.84% of American Healthcare REIT worth $49,149,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in AHR. Wolff Wiese Magana LLC bought a new stake in shares of American Healthcare REIT during the 1st quarter worth $25,000. Spirit of America Management Corp NY bought a new stake in shares of American Healthcare REIT during the 1st quarter worth $30,000. Physician Wealth Advisors Inc. bought a new stake in shares of American Healthcare REIT during the 2nd quarter worth $34,000. Avalon Trust Co bought a new stake in shares of American Healthcare REIT during the 1st quarter worth $36,000. Finally, Continuum Advisory LLC bought a new stake in shares of American Healthcare REIT during the 1st quarter worth $37,000. 16.68% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on AHR shares. Baird R W upgraded shares of American Healthcare REIT to a "strong-buy" rating in a research report on Thursday, July 17th. Truist Financial boosted their price target on shares of American Healthcare REIT from $44.00 to $46.00 and gave the stock a "buy" rating in a research note on Tuesday, August 26th. JMP Securities boosted their price target on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a "market outperform" rating in a research note on Monday, August 11th. Morgan Stanley reissued an "overweight" rating on shares of American Healthcare REIT in a research note on Wednesday, September 3rd. Finally, UBS Group assumed coverage on shares of American Healthcare REIT in a research note on Friday, September 19th. They issued a "buy" rating and a $51.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $44.11.

American Healthcare REIT Price Performance

AHR stock opened at $40.58 on Friday. The firm's 50-day moving average price is $41.69 and its two-hundred day moving average price is $36.72. American Healthcare REIT, Inc. has a 12-month low of $24.21 and a 12-month high of $43.52. The stock has a market capitalization of $6.84 billion, a price-to-earnings ratio of -184.45, a PEG ratio of 2.08 and a beta of 0.98. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The firm had revenue of $542.50 million for the quarter, compared to analysts' expectations of $539.49 million. During the same quarter in the previous year, the company earned $0.33 earnings per share. The company's revenue for the quarter was up 7.5% compared to the same quarter last year. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, equities analysts predict that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th will be given a $0.25 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.5%. American Healthcare REIT's payout ratio is presently -454.55%.

Insider Activity

In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the business's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the transaction, the executive vice president owned 59,100 shares in the company, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.92% of the company's stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.